| MDL | MFCD23381068 |
|---|---|
| Molecular Weight | 391.42 |
| Molecular Formula | C22H21N3O4 |
| SMILES | O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CC)C5=CC=CC=C5N=C4C3=C2N)=O |
TH1338 (compound 3b), an orally active camptothecin derivative and a potent chemotherapeutic agent for cancer , demonstrates excellent cytotoxic potency against human tumor cell lines in vitro. TH1338 (compound 3b) possesses significant brain penetration, favorable efflux pump properties, and hematological toxicity profile [1] [2] .
TH1338 (compound 3b) demonstrates significant brain penetration when dosed orally in mice
[1]
.
TH1338 (compound 3b) exhibits potent anti-tumor activity in H460 (NSCLC) human tumor xenograft model
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
| Cell Line: |
H460 (NSCLC) human tumor xenograft model.
|
| Concentration: | 40 mg/kg. |
| Incubation Time: | Oral gavage. |
| Result: | Exhibited superior antitumor activity. |
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 10 mg/mL ( 25.55 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.5548 mL | 12.7740 mL | 25.5480 mL |
| 5 mM | 0.5110 mL | 2.5548 mL | 5.1096 mL |
| 10 mM | 0.2555 mL | 1.2774 mL | 2.5548 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 1.82 mg/mL (4.65 mM); Clear solution